This study evaluates the use of N-acetylcysteine in the treatment of alcohol and cocaine use
disorders. Alcohol users will be split in two groups, one will receive the active
N-acetylcysteine and the other placebo. The same division will occur with cocaine users. The
effects of N-acetylcysteine in adherence, abstinence, psychiatric symptoms and stress
biomarkers will be evaluated.